Skip to main content
SpringerLink
Log in

Vismodegib treatment for recurrent basal cell carcinoma – a successful case report

  • Residents’ Corner
  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012; 166: 1069–80.

    Article  CAS  PubMed  Google Scholar 

  2. Peris K, Fargnoli MC, Garbe C, et al. Diagnosis and treatment of basal cell carcinoma: european consensus-based interdisciplinary guidelines. Eur J Cancer 2019; 118: 10–34.

    Article  CAS  PubMed  Google Scholar 

  3. van Loo E, Mosterd K, Krekels GA, et al. Surgical excision versus Mohs’ micrographic surgery for basal cell carcinoma of the face: a randomised clinical trial with 10 year follow-up. Eur J Cancer 2014; 50: 3011–20.

    Article  PubMed  Google Scholar 

  4. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Basal cell skin cancer. Version 2.2021. https://www.nccn.org/professionals/physician_gls/pdf/nmsc.pdf (Accessed on May 13, 202).

  5. Danhof R, Lewis K, Brown M. Small molecule inhibitors of the hedgehog pathway in the treatment of basal cell carcinoma of the Skin. Am J Clin Dermatol 2018; 19: 195–207.

    Article  PubMed  Google Scholar 

  6. Frampton JE, Basset-Séguin N. Vismodegib: a review in advanced basal cell carcinoma. Drugs 2018; 78: 1145–56.

    Article  PubMed  Google Scholar 

  7. Dréno B, Kunstfeld R, Hauschild A, et al. Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial. Lancet Oncol 2017; 18: 404–12.

    Article  PubMed  Google Scholar 

  8. Puig S, Serra-Guillén C, Pérez-Pastor G, Martínez-Domenech Á, Fernández-de-Misa Cabrera R. Experience with sonidegib in patients with advanced basal cell carcinoma: case reports. Drugs Context 2022; 11: 2022–3-8.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Herms F, Luc H, Bagot M, et al. Follow-up of patients with complete remission of locally advanced basal cell carcinoma treated with vismodegib after treatment discontinuation: a retrospective multicentric French study [abstract no. 9535]. J Clin Oncol 2017; 35: 9535.

    Article  Google Scholar 

Download references

Acknowledgements

The patient in this manuscript has given informed consent to the publication of her case details.

Author information

Authors and Affiliations

  1. Dermatology Department, Centro Hospitalar e Universitário de Santo António, Santo António, Portugal

    Ana Maria Lé, Miguel Nogueira & Miguel Horta

  2. Oncology Department, Centro Hospitalar e Universitário de Santo António, Santo António, Portugal

    Alexandra Araújo

Authors
  1. Ana Maria Lé
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Miguel Nogueira
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexandra Araújo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Miguel Horta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ana Maria Lé.

Ethics declarations

Conflict of interest: none.

Additional information

Financial support: none.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lé, A.M., Nogueira, M., Araújo, A. et al. Vismodegib treatment for recurrent basal cell carcinoma – a successful case report. Eur J Dermatol 33, 332–333 (2023). https://doi.org/10.1684/ejd.2023.4508

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2023.4508

Search

Navigation